Director of Financial Reporting

About Avadel Pharmaceuticals plc

Who We Are : Avadel Pharmaceuticals plc (Nasdaq : AVDL) is a biopharmaceutical company focused on transforming medicines to transform lives. Our approach includes applying innovative solutions to the development of medications that address the challenges patients face with current treatment options. Oxybate therapy is currently the standard of care for the treatment of excessive daytime sleepiness (EDS) and cataplexy in patients living with narcolepsy. However, other approved oxybate products are immediate release formulations requiring two nightly doses - one dose at bedtime and the second dose 2.5-4 hours later, in the middle of the night. LUMRYZ

sodium oxybate) extended release for oral suspension, applies our proprietary drug delivery technology to allow for a single bedtime dose, eliminating the need to have a forced awakening during the middle of the night and giving patients the chance for an uninterrupted night?s sleep. An extended-release medication sounds like a simple innovation, but it has been lacking for more than 20 years prior to our May 1, 2023 approval, and we believe this can be transformative for people with narcolepsy. For more information, please visit www.avadel.com or check out narcolespydisrupts.com.

What We Do : FDA-approved LUMRYZ (sodium oxybate) is a central nervous system depressant indicated for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients 7 years of age and older with narcolepsy. The FDA found LUMRYZ to be clinically superior to currently marketed twice-nightly oxybate products and granted LUMRYZ seven years of Orphan Drug Exclusivity for adults on May 1, 2023, and again for pediatric patients 7 years and older on October 16, 2024. In both instances, FDA found that LUMRYZ makes a major contribution to patient care over currently available, twice-nightly oxybate products by providing a once-nightly dosing regimen that avoids nocturnal awakening to take a second dose.

How We Work : At Avadel, patients are the reason we exist, and our employees are our greatest competitive advantage ? our ?secret sauce.? The way we work is as important as the results we achieve. Our employees work together as ONE team and live our Values, which is what makes working at Avadel so special and why we will win for patients. Our ONE Team approach fosters a culture based on being relentless for patients, having confidence with humility , being courageous , taking insights to impact, and togetherness . In everything we do, we live the Avadel Values so we can be our best for our patients, our community and each other.

We need individuals who will dive in, roll up their sleeves, and join us to continue the LUMRYZ launch and our mission to serve the narcolepsy community.

Position Summary :

The Director, Financial Reporting will be a critical member of the finance team as Avadel prepares to launch and commercial Lumryz

for people living with narcolepsy. The Director, Financial Reporting is primarily responsible for managing the preparation of the Company?s SEC filings, technical accounting research and analysis, and for the internal preparation and review of ad hoc reports and analyses. The Director, Financial Reporting reports to the Senior Director, Financial Reporting & Analysis, with great exposure to executives within the organization. This critical business role requires a demonstrated ability to impact and influence at all levels of the organization, be technically sound on all internal controls over financial reporting related processes and topics and be the subject matter expert as Avadel is impacted by changing external regulations or guidance demand.

Essential Functions :

External Reporting Activities :

• Oversee the preparation and review of a) the Quarterly and Annual Reports on Form 10-Q / K and b) annual consolidated Irish Statutory Accounts Report, including Corporate Sustainability Reporting Directive (CSRD) disclosures, and manage the internal and external review for these documents.
• Own the SEC calendar to inform parties of necessary deadline adherence for the following processes : financial close, audit committee package, press release and 10-Q / K.
• Coordinate the preparation and review of the quarterly audit committee package.
• Monitor and ensure timely identification and compliance with evolving accounting guidance, provide US GAAP interpretation, and prepare technical memorandums that document Issues in a clear, logical, and comprehensive manner.
• Communicate and explain accounting issues and evolving accounting guidance to the management team.
• Collaborate with external auditors and external legal counsel on external financial statements and accounting issues to ensure auditor agreement with company decisions on accounting disclosures and issues.
• Assist in the coordination of annual audit and quarterly review activities of external auditors.
• Supervise and mentor a direct report, providing guidance, support, and performance feedback to ensure team success.

Internal Reporting Activities :

Experience and Qualifications :

Avadel is committed to facilitating an open, honest, inclusive, transparent, and productive work environment where we work together as ONE team and ONE culture to be our best for patients, customers, and each other. Avadel is committed to equal employment opportunities and non-discrimination in employment. We believe that all employees and applicants should be treated with courtesy, dignity, and respect. Avadel does not discriminate in employment on the basis of race, color, religion, sex, sexual orientation, national origin, age, disability, genetic information, marital status, ancestry, gender, gender identity, pregnancy, status as a covered veteran, or any other characteristic protected by federal, state, and / or local law. It is our intent to comply with federal, state, and local laws, regulations, and guidelines in our employment practices and in our service to our clients. This policy applies to all terms and conditions of employment including, but not limited to, hiring, placement, promotion, termination, layoff, recall, transfer, leaves of absence, compensation, and training.

Please see job description

PI260192265

Please see job description